ロード中...
吉非替尼治疗32例肺腺癌脑转移的临床经验
BACKGROUND AND OBJECTIVE: Brain metastasis was frequent in non-small cell lung cancer (NSCLC) patients with poor prognosis. Gefitinib was an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor which has been used in the treatment of NSCLC. Our study was to evaluate the efficacy and tox...
保存先:
| 出版年: | Zhongguo Fei Ai Za Zhi |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
中国肺癌杂志编辑部
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000113/ https://ncbi.nlm.nih.gov/pubmed/26383979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.09.05 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|